Phase 2b Study of ALTO-100 in MDD
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Major Depressive Disorder
Related studies linked through entity extraction aliases.
N2O for Acute Suicidality and Depression in the ED
- Status
- WITHDRAWN
- Phase
- PHASE2
HypErthermia as an Additional Treatment for the Biology and Experience of Depression: Study 2
- Status
- COMPLETED
- Phase
- NA
The Effect of Intradermal Acupuncture on Gallbladder Meridian Points on Cerebral Hemodynamics in Relevant Brain Regions for Major Depressive Disorder Based on fNIRS Technology
- Status
- UNKNOWN
- Phase
- NA
Amygdala Neurofeedback for Depression - Large Scale Clinical Trial
- Status
- RECRUITING
- Phase
- NA
Study of Virtual Reality-based Medical Device for Patients with Depressive Disorder
- Status
- COMPLETED
- Phase
- NA
Low Intensity Ultrasound Neuromodulation of Repetitive Negative Thinking In Depression
- Status
- COMPLETED
- Phase
- NA
Feasibility of Resistance Exercise to Treat Major Depression Via Cerebrovascular Mechanisms
- Status
- COMPLETED
- Phase
- NA
Transcranial Magnetic Stimulation Theta Burst (TMS), Depression and Smoking.
- Status
- UNKNOWN
- Phase
- NA
Musical Attention Control and Executive Function Training for Adults With MDD
- Status
- COMPLETED
- Phase
- NA
Augmenting Single-session Behavioral Activation (BA) With Delta-beta Transcranial Alternating Current Stimulation (tACS) for the Treatment of Depression
- Status
- COMPLETED
- Phase
- NA
Evolution of the Sensory Profile in Depression
- Status
- COMPLETED
- Phase
- N/A
A Treatment for Depression Via a Gamified Mobile Phone Application Based on a New Cognitive Model
- Status
- COMPLETED
- Phase
- NA
Multi-domain Psychoeducation Self-management Program for Adults With MDD in Singapore
- Status
- UNKNOWN
- Phase
- NA
40 Hz Light Neurostimulation for Patients With Depression (FELIX)
- Status
- RECRUITING
- Phase
- NA
Psilocybin for Major Depressive Disorder
- Status
- WITHDRAWN
- Phase
- PHASE2
Mindful Self-Compassion for Anxiety Disorders and Depression
- Status
- RECRUITING
- Phase
- NA
An Open-label, Adaptive Design, Positron Emission Tomography Study in Healthy Male Participants to Characterize Receptor Occupancy by MIJ821 in the Brain
- Status
- COMPLETED
- Phase
- PHASE1
Xanamem® in Adults With Major Depressive Disorder and Impaired Cognition (XanaCIDD)
- Status
- COMPLETED
- Phase
- PHASE2
Zuranolone Pharmacokinetics (PK) and Safety Study Adolescent Participants With Major Depressive Disorder (MDD)
- Status
- COMPLETED
- Phase
- PHASE1